Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 2Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 65Lymphoma 59Lymphoma, Follicular 53Lymphoma, Large B-Cell, Diffuse 51Lymphoma, B-Cell 50Leukemia, Lymphocytic, Chronic, B-Cell 34Lymphoma, Non-Hodgkin 33Recurrence 27Leukemia 22Lymphoma, Mantle-Cell 20Burkitt Lymphoma 18Lymphoma, T-Cell, Peripheral 17Leukemia, Myeloid, Acute 15Hodgkin Disease 15Waldenstrom Macroglobulinemia 14Hematologic Neoplasms 14Lymphoma, B-Cell, Marginal Zone 13Multiple Myeloma 12Lymphoma, T-Cell, Cutaneous 12Lymphoma, Extranodal NK-T-Cell 12Neoplasms 11Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Leukemia, B-Cell 8Motor Activity 7Myelodysplastic Syndromes 6Mycosis Fungoides 6Sezary Syndrome 5Neoplasm, Residual 5Pain 4Neoplasms, Plasma Cell 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Carcinoma, Endometrioid × Lymphoid × Clear all
NCT06468215 2024-07-16

Fertility Sparing Therapy for Patients With Stage IA G2 Endometrial Cancer

Peking University People's Hospital

Phase NA Not yet recruiting
16 enrolled
GynecologicLymphoid

Lymphoma, Follicular, Endometrial Neoplasms, Carcinoma, Endometrioid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡